Advisor Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$1.09M Buy
5,307
+1,536
+41% +$346K 0.08% 273
2022
Q1
$912K Buy
3,771
+102
+3% +$23.6K 0.06% 328
2021
Q4
$893K Buy
3,669
+649
+21% +$148K 0.05% 336
2021
Q3
$617K Sell
3,020
-13
-0.4% -$2.78K 0.04% 423
2021
Q2
$626K Buy
3,033
+313
+12% +$63K 0.04% 428
2021
Q1
$518K Buy
2,720
+160
+6% +$29.7K 0.04% 474
2020
Q4
$477K Buy
2,560
+465
+22% +$86.8K 0.04% 467
2020
Q3
$367K Buy
2,095
+169
+9% +$27K 0.03% 475
2020
Q2
$296K Buy
1,926
+229
+13% +$34.9K 0.03% 520
2020
Q1
$237K Buy
+1,697
New +$254K 0.03% 500

Other funds holding STE

Advisor Partners's STE Position: Q2 2022 in Review

Advisor Partners increased its Steris (STE) stake by 41% in Q2 2022, buying an estimated $346K and bringing the position to 5,307 shares worth $1.09M. The position accounts for 0.08% of the portfolio, ranked #273.

Advisor Partners first reported a position in STE in Q1 2020 and has held it in 10 quarters since. 665 funds tracked by Wall St. Rank hold STE as of Q2 2022.

  • Advisor Partners held 5,307 shares of Steris worth $1.09M as of Q2 2022.
  • Advisor Partners bought 1,536 Steris shares in Q2 2022, an estimated $346K.
  • Steris made up 0.08% of Advisor Partners's portfolio in Q2 2022, its #273 holding.
  • Advisor Partners first reported a position in Steris in Q1 2020 and has held it in 10 quarters since.
  • 665 funds tracked by Wall St. Rank held Steris as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.